HomeCOGT • NASDAQ
add
Cogent Biosciences Inc
Previous close
$7.47
Day range
$7.36 - $7.65
Year range
$3.67 - $13.50
Market cap
711.36M USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 62.40M | 44.33% |
Net income | -58.35M | -51.21% |
Net profit margin | — | — |
Earnings per share | -0.62 | -8.87% |
EBITDA | -61.80M | -44.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 435.74M | 97.83% |
Total assets | 476.11M | 80.89% |
Total liabilities | 53.78M | 35.68% |
Total equity | 422.33M | — |
Shares outstanding | 95.61M | — |
Price to book | 3.57 | — |
Return on assets | -39.52% | — |
Return on capital | -43.49% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -58.35M | -51.21% |
Cash from operations | -52.53M | -32.93% |
Cash from investing | 1.04M | -98.26% |
Cash from financing | 214.06M | 48,002.70% |
Net change in cash | 162.57M | 681.15% |
Free cash flow | -31.24M | -15.20% |
About
Founded
2014
Headquarters
Website
Employees
164